Mesalamine-induced myocarditis following diagnosis of Crohn's disease: A case report
Mesalamine is a common treatment for Crohn's disease, and can be rarely associated with myocarditis through a mechanism of drug hypersensitivity. We present the case of a 19-year-old male who developed chest pain two weeks after beginning mesalamine ...
Carlos Galvão Braga+7 more
doaj
Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease [PDF]
Avellini, Claudio+3 more
core +1 more source
Budesonide MMX and mesalamine to induce remission in patients with ulcerative colitis [PDF]
COTTONE, Mario, Criscouli, Sinagra E
core +1 more source
Mesalamine-induced pleuritis in a patient with ulcerative colitis [PDF]
Alessandro Tozzi+5 more
openalex +1 more source
Adherence in ulcerative colitis: an overview
Anna Testa,1 Fabiana Castiglione,1 Olga Maria Nardone,1 Giorgio L Colombo2 1Gastroenterology, University of Naples Federico II, Naples, 2Department of Drug Sciences, University of Pavia, Pavia, Italy Abstract: Medication adherence is an important ...
Testa A+3 more
doaj
Exam 2: Progression to Colorectal Neoplasia in Ulcerative Colitis: Effect of Mesalamine [PDF]
Michael B. Fallon
openalex +1 more source
Consistency of coating thickness of delayed-release mesalamine formulations: drug release characteristics across the pH range found in the GI tract of patients with ulcerative colitis [PDF]
Srini Tenjarla+2 more
openalex +1 more source
Failure of mesalamine to resolve the diarrhea of microscopic colitis suggests a comorbid illness
Charles Randall+2 more
openalex +1 more source
Once daily dosing of delayed-release oral mesalamine for maintenance of remission of Ulcerative Colitis (the QDIEM Trial): 6 and 12 month results [PDF]
William J. Sandborn+9 more
openalex +1 more source
Efficacy of mesalamine rectal gel in distal ulcerative colitis. A pilot study
Guy Aumais+6 more
openalex +1 more source